|
End-of-day quote
Bulgaria S.E.
30/10/2026
|
5-day change | 1st Jan Change | ||
| 3.360 EUR | +1.20% |
|
+1.20% | +135.86% |
| 09-21 | Sopharma AD Reports Sales Results for the Month and Year to Date Ended August 2026 | CI |
| 08-28 | Sopharma AD Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 3.36B 2.02B 1.81B 1.66B 1.51B 2.82B 192B 2.87B 19.84B 7.97B 101B 7.58B 7.42B 318B | P/E 2024 |
12.3x | P/E 2025 | 7.16x |
|---|---|---|---|---|---|
| Enterprise Value | 3.9B 2.35B 2.1B 1.93B 1.75B 3.27B 223B 3.33B 23.04B 9.25B 117B 8.8B 8.61B 369B | EV / Sales 2024 |
0.66x | EV / Sales 2025 | 0.76x |
| Free-Float |
31.06% | Yield 2024 |
2.68% | Yield 2025 | 5.02% |
Bulgaria S.E.EUR
| Markets | Quality | ||
|---|---|---|---|
Bulgaria S.E.
| SFA | End-of-day quote | |
Warsaw S.E.
| SPH | Delayed | |
|
Deutsche Boerse AG
| 3JR | Delayed |
| 1 day | +1.20% | ||
| 1 week | +1.20% | ||
| 1 month | +29.73% | ||
| 3 months | +74.55% | ||
| 6 months | +94.22% | ||
| Current year | +135.86% |
| 1 week | 3.21 |  | 3.36 |
| 1 month | 2.49 | | 3.37 |
| Current year | 1.41 | | 3.37 |
| 1 year | 1.34 | | 3.37 |
| 3 years | 0.94 | | 3.37 |
| 5 years | 0.68 | | 3.37 |
| 10 years | 0.41 | | 3.37 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ognian Donev
CEO | Chief Executive Officer | 42 | 01/10/2000 |
Boris Borisov
DFI | Director of Finance/CFO | - | 01/01/2002 |
Ivaylo Mechev
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Ognian Donev
CHM | Chairman | 42 | 19/05/2010 |
| Director/Board Member | 63 | 19/05/2010 | |
| Director/Board Member | 61 | 12/07/2011 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 30/9/20 | Donev Investments Ad
| Buy | Company | 25,489 | 0.0189% | |
| 30/9/20 | Buy | Chief Executive Officer | 12,000 | 0.0089% | ||
| 29/9/20 | Donev Investments Ad
| Buy | Company | 9,000 | 0.0067% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.20% | +1.20% | +141.54% | +175.44% | 2.02B | |
| +5.89% | +1.33% | -37.23% | +7.17% | 15.49B | |
| +3.15% | -0.76% | -6.75% | -1.29% | 6.5B | |
| +2.38% | +0.43% | -16.47% | +1.18% | 6.44B | |
| +2.54% | -1.40% | -51.29% | -38.72% | 5.82B | |
| -17.06% | -24.95% | -22.38% | -39.83% | 4.9B | |
| +5.00% | +4.34% | +8.35% | -3.08% | 4.82B | |
| +0.22% | +6.79% | -21.38% | -35.68% | 3.16B | |
| +9.99% | +11.56% | +10.83% | -14.87% | 3.47B | |
| +1.44% | +3.86% | -21.60% | +28.54% | 3.08B | |
| Average | +1.48% | -0.23% | -1.64% | +7.89% | 5.57B | |
| Weighted average by Cap. | +2.24% | -0.61% | -16.25% | -0.84% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.14B 1.28B 1.15B 1.06B 959M 1.79B 122B 1.83B 12.62B 5.07B 64.18B 4.82B 4.72B 202B | 2.63B 1.58B 1.42B 1.3B 1.18B 2.21B 150B 2.25B 15.53B 6.24B 78.98B 5.93B 5.81B 249B |
| Net income | 77.85M 46.75M 41.87M 38.52M 34.9M 65.24M 4.44B 66.46M 459M 184M 2.34B 175M 172M 7.36B | 134M 80.19M 71.82M 66.06M 59.86M 112M 7.61B 114M 788M 316M 4.01B 301M 295M 12.63B |
| Net Debt | 444M 267M 239M 220M 199M 372M 25.33B 379M 2.62B 1.05B 13.32B 1B 980M 42.02B | 541M 325M 291M 268M 243M 454M 30.87B 462M 3.19B 1.28B 16.24B 1.22B 1.19B 51.21B |
Employees
6,049
Sector
Drug Retailers
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | €3.360 | +1.20% | 29,134 |
| 29/10/26 | €3.320 | +1.22% | 60,549 |
| 28/10/26 | €3.280 | +0.31% | 39,789 |
| 27/10/26 | €3.270 | -0.61% | 56,773 |
| 26/10/26 | €3.290 | -0.90% | 30,115 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SFA Stock
Select your edition
All financial news and data tailored to specific country editions
